Literature DB >> 17827165

Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation.

Peeter Karihtala1, Ylermi Soini, Päivi Auvinen, Raija Tammi, Markku Tammi, Veli-Matti Kosma.   

Abstract

Reactive oxygen species (ROS), including nitric oxide (NO(*)), are associated with all steps of carcinogenesis. Hyaluronan (HA), a high-molecular-mass glycosaminoglycan overexpressed in a variety of human malignancies also has ROS-scavenging properties. We histochemically studied the level of HA in breast carcinoma cells and their stroma and compared it with the expression of NO(*) synthases (NOSs), major antioxidant enzymes, and nitrotyrosine. We also assessed whether the level of HA correlates with traditional prognostic factors of breast cancer and survival. Stromal HA level was moderate or high in all the samples studied (n=185), and 84% of the lesions showed HA-positive carcinoma cells. Intense stromal HA signal was associated with high neuronal NOS expression (p=0.009), whereas tumor-cell associated HA was inversely correlated with nitrotyrosine expression (p=0.027). Of the traditional prognostic factors, tumor cell-associated HA was correlated with poor differentiation (p=0.011), and high stromal HA levels were associated with aggressive features of the carcinomas such as large primary tumor (p=0.002), poor differentiation (p=0.019), and estrogen (p=0.012) and progesterone receptor negativity (p=0.009). High stromal HA level also significantly predicted poorer survival. The strong positive correlation between neuronal NOS and stromal HA could reflect NO(*)-stimulated synthesis of HA, an extracellular matrix alteration that favors breast cancer progression. Furthermore, it is suggested that, while acting as a scavenger of NO(*)-derived radicals, cell-associated HA undergoes partial fragmentation, release from receptors, and further degradation in lysosomes, and thus becomes undetectable in histological sections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827165     DOI: 10.1369/jhc.7A7270.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  13 in total

1.  Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction.

Authors:  Xiuping Chen; Bradley T Andresen1; Michael Hill; Jing Zhang; Frank Booth; Cuihua Zhang
Journal:  Curr Hypertens Rev       Date:  2008-11

2.  Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.

Authors:  Laura R Bohrer; Pavlina Chuntova; Lindsey K Bade; Thomas C Beadnell; Ronald P Leon; Nicholas J Brady; Yungil Ryu; Jodi E Goldberg; Stephen C Schmechel; Joseph S Koopmeiners; James B McCarthy; Kathryn L Schwertfeger
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

Review 3.  Hyaluronan-dependent pericellular matrix.

Authors:  Stephen P Evanko; Markku I Tammi; Raija H Tammi; Thomas N Wight
Journal:  Adv Drug Deliv Rev       Date:  2007-08-14       Impact factor: 15.470

4.  Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells.

Authors:  Ibrahima Youm; Vivek Agrahari; James B Murowchick; Bi-Botti C Youan
Journal:  Pharm Res       Date:  2014-03-19       Impact factor: 4.200

5.  CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.

Authors:  Nicola Montgomery; Ashleigh Hill; Suzanne McFarlane; Jessica Neisen; Anthony O'Grady; Susie Conlon; Karin Jirstrom; Elaine W Kay; David J J Waugh
Journal:  Breast Cancer Res       Date:  2012-05-23       Impact factor: 6.466

Review 6.  Hyaluronan, Inflammation, and Breast Cancer Progression.

Authors:  Kathryn L Schwertfeger; Mary K Cowman; Patrick G Telmer; Eva A Turley; James B McCarthy
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

7.  Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.

Authors:  Liqun Chen; Lilly Y W Bourguignon
Journal:  Mol Cancer       Date:  2014-03-08       Impact factor: 27.401

8.  Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone Suppresses the Secretory Processes That Ensure the Invasion of Neutrophils into Tissues and Induce Inflammation.

Authors:  Svetlana I Galkina; Natalia V Fedorova; Alexander L Ksenofontov; Ekaterina A Golenkina; Marina V Serebryakova; Vladimir I Stadnichuk; Ludmila A Baratova; Galina F Sud'ina
Journal:  Biomedicines       Date:  2022-01-28

9.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30

10.  Discriminant function based on parameters of hyaluronic acid metabolism and nitric oxide to differentiate metastatic from non-metastatic colorectal cancer patients.

Authors:  Hatem A El-Mezayen; El-Shahat A Toson; Hossam Darwish; Ehab El-Badry
Journal:  Tumour Biol       Date:  2012-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.